Melatonin Level and Postoperative Analgesia Consumption in Bariatric Surgery Patients.

NCT03107702 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2017-04-11

No results posted yet for this study

Summary

Bariatric surgical procedures are associated with low short-term mortality and may be associated with long-term reductions in all-cause, cardiovascular, and cancer-related mortality. This surgeries are major surgeries include risk of mortality still.

Melatonin is a hormone secreted from the pineal gland. Melatonin is an antioxidant, antinociceptive, hypnotic, anticonvulsant, neuroprotective, anxiolytic, sedative and analgesic. Melatonin is neurohormone with the profile of a novel hypnotic-anesthetic agent.

The purpose of this study is to investigate the preoperative, perioperative and postoperative melatonin levels in bariatric surgery under general anesthesia and to investigate the relationship between melatonin level and analgesia requirement.

Conditions

  • Bariatric Surgery
  • Melatonin
  • POSTOPERATIVE PAIN

Interventions

DIAGNOSTIC_TEST

melatonin

the relationship between melatonin level and analgesia requirement.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Türkan Toğal, Prof. · Inonu University Faculty of Medicine

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-29
Primary Completion
2017-06-30
Completion
2017-07-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03107702 on ClinicalTrials.gov